The COX (cyclo-oxygenase) pathway generates the reactive lipid electrophile 15d-PGJ 2 (15-deoxy-12,14 -prostaglandin J 2 ), which forms covalent protein adducts that modulate cell signalling pathways. It has been shown that this regulates important biological responses, including protection against oxidative stress, and supports the proposal that 15d-PGJ 2 has pharmacological potential. Protective pathways activated by 15d-PGJ 2 include those controlling the synthesis of the intracellular antioxidants GSH and the enzyme HO-1 (haem oxygenase-1). The induction of the synthesis of these intracellular antioxidants is, in large part, regulated by covalent modification of Keap1 (Kelchlike erythroid cell-derived protein with cap'n'collar homologyassociated protein 1) by the lipid and the subsequent activation of the EpRE (electrophile-response element). For the first time, we show that the potency of 15d-PGJ 2 as a signalling molecule in endothelial cells is significantly enhanced by the accumulation of the covalent adduct with 15d-PGJ 2 and endogenous Keap1 over the time of exposure to the prostaglandin. The consequence of this finding is that signalling initiated by electrophilic lipids differs from agonists that do not form covalent adducts with proteins because the constant generation of very low concentrations of 15d-PGJ 2 can lead to induction of GSH or HO-1. In the course of these studies we also found that a substantial amount (97-99 %) of exogenously added 15d-PGJ 2 is inactivated in the medium and does not enter the cells to initiate cell signalling. In summary, we propose that the accumulation of covalent adduct formation with signalling proteins provides a mechanism through which endogenous intracellular formation of electrophilic lipids from COX can exert an anti-inflammatory effect in vivo.
INTRODUCTION
It has long been recognized that enzymes such as COX (cyclooxygenase) generate signalling molecules through the controlled oxidation of lipids [1, 2] . A subclass of these signalling molecules can act through mechanisms which involve the specific covalent modification of proteins [3] [4] [5] [6] . For example, some of the cyclopentenone prostaglandins contain α,β-unsaturated carbonyl groups and an associated electrophilic centre. This results in reactivity with nucleophilic amino acid residues such as cysteine [3, [7] [8] [9] . In this respect, the cyclopentenone 15d-PGJ 2 (15-deoxy-12,14 -prostaglandin J 2 ) is particularly interesting since it is formed in vivo downstream of COX-2 from the dehydration of PGD 2 (prostaglandin D 2 ) [10, 11] . It is now clear that 15d-PGJ 2 has distinct signalling properties which cannot be explained solely by its interaction with PPARγ (peroxisome-proliferator-activated receptor γ ) or other established prostaglandin receptors [8, 10, [12] [13] [14] . The electrophilic carbons are critical for these biological actions of 15d-PGJ 2 , since closely related compounds lacking this group cannot activate the PPARγ -independent signalling pathways [10, 12] . These PPARγ -independent pathways are associated with the formation of covalent lipid-protein adducts with a sub-proteome that includes members such as Keap1 (Kelchlike erythroid cell-derived protein with cap'n'collar homologyassociated protein 1), ras, thioredoxin and NF-κB (nuclear factor κB) in the cell [7, 8, [15] [16] [17] [18] [19] . We have termed this family of proteins the electrophile-responsive proteome [3, 5] . Interestingly, the effects of covalent protein modification with a signalling molecule such as Keap1 have not been characterized fully, and this has led to an underappreciation of the potential role of 15d-PGJ 2 in cytoprotective signalling.
An important protein belonging to the electrophile-responsive proteome is Keap1, a cytosolic protein that binds the transcription factor Nrf-2 (nuclear factor erythroid 2-related factor 2) and controls the levels available for nuclear translocation [20] . Covalent modification of critical thiol residues of Keap1 decreases the proteasomal degradation of Nrf-2, and results in the translocation of Nrf-2 to the nucleus, where it heterodimerizes with other transcription factors to increase the expression of proteins under the control of the EpRE (electrophile-response element) [20] . Such proteins include HO-1 (haem oxygenase-1) and the enzyme responsible for GSH synthesis, glutamatecysteine ligase. It has been shown that HO-1 expression is induced by isolated cyclopentenone prostaglandins [21] [22] [23] [24] . An important question in the redox signalling field is whether sufficient amounts of electrophilic lipids such as 15d-PGJ 2 can be generated by COX-2 to activate signalling pathways. Indeed, free 15d-PGJ 2 has been measured in vivo, is elevated during the late stages Abbreviations used: BAEC, bovine aortic endothelial cell; BT, biotinylated; COX, cyclo-oxygenase; cyt c, cytochrome c; DTPA, diethylenetriaminepentaacetic acid; EpRE, electrophile-response element; FBS, fetal bovine serum; HO-1, haem oxygenase-1; HRP, horseradish peroxidase; Keap1, Kelch-like erythroid cell-derived protein with cap'n'collar homology-associated protein 1; LSD, least squares difference; NF-κB, nuclear factor κB; Nrf-2, nuclear factor erythroid 2-related factor 2; PGD 2 , prostaglandin D 2 ; 15d-PGJ 2 , 15-deoxy-12,14 -prostaglandin J 2 ; PIC, protease inhibitor cocktail; PPARγ, peroxisomeproliferator-activated receptor γ; ROS, reactive oxygen species; TBS-T, Tris-buffered saline with Tween 20.
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of inflammation and is associated with the COX-2-dependent induction of intracellular antioxidants [24] [25] [26] [27] . For example, in a recent study, the levels of free 15d-PGJ 2 were reported in the nanomolar range, a level insufficient to activate PPARγ , although more recent reports suggest that PPARγ may be activated at biologically relevant concentrations [28] [29] [30] . This raises a critical question important for understanding how lipid electrophiles, such as 15d-PGJ 2 , mediate cell signalling: what is the 'real' concentration to which cells are exposed and how does this relate to the formation of the covalent protein adducts which modulate the biological effects of the lipid? Other factors which are likely to affect the availability of electrophiles such as 15d-PGJ 2 to initiate cell signalling are the competition with non-specific binding sites in the medium or metabolism and conjugation with GSH through the enzymatic action of glutathione transferases [17, [31] [32] [33] . To approach these questions, we investigated the relationship between exogenously added 15d-PGJ 2 and the levels of covalent adduct formation with proteins in endothelial cells in culture.
In addition, we hypothesized that covalent modification of signalling proteins over time will increase the sensitivity of the pathways activated by the EpRE system through the accumulation of covalent adducts with Keap1. Accordingly, we have designed experiments to characterize the conditions of exposure required to activate the EpRE in endothelial cells by 15d-PGJ 2 , measured by increases in both cellular GSH and HO-1. In the present study, we demonstrate for the first time that adduct formation with endogenous Keap1 and low amounts of 15d-PGJ 2 can accumulate over time, leading to increased levels of cellular GSH and HO-1. In addition, a substantial proportion of the 15d-PGJ 2 is rapidly inactivated under cell culture conditions and is not available for activation of cell signalling pathways. The implications of these data for understanding the mechanisms of reactive lipid signalling in vivo are profound, since they suggest that the accumulation of a signal can occur over time at biologically relevant levels of 15d-PGJ 2 . These findings support the hypothesis that this and similar electrophiles can contribute to the regulation of the EpRE in vivo.
MATERIALS AND METHODS
All biochemicals were purchased from Sigma, except where noted.
Cell culture
BAECs (bovine aortic endothelial cells) were prepared and used between the fourth and tenth passage as described previously [34] and cultured in six-well plates in DMEM (Dulbecco's modified Eagle's medium) (Cellgro) containing 10 % FBS (fetal bovine serum) (Atlanta Biologicals), 5.6 mM glucose, 2 mM glutamine (Gibco) and penicillin/streptomycin (Gibco). After reaching confluence, medium was replaced with medium containing 0.5 % FBS for 24 h before exposure to the lipid under the conditions described for each experiment.
Determination of lipid concentration and cell treatment
The 15d-PGJ 2 (Cayman) and BT-15d-PGJ 2 (biotinylated 15d-PGJ 2 ) concentrations were measured by absorbance at 306 nm using the molar absorption coefficient 12 000 M −1 · cm −1 in ethanol. The lipid concentration in aqueous medium was recalibrated by absorbance at 315 nm using the molar absorption coefficients 9588 M −1 · cm −1 and 9014 M −1 · cm −1 for unmodified and biotinylated lipids respectively. Confluent cells were treated with lipid under the conditions described, and all cellular responses were compared with a vehicle (ethanol) control. In the comparison of the bolus and sequential addition of 15d-PGJ 2 over a period of 3 days, the experiment was initiated at a confluence of approx. 80 % at day 1.
Determination of lipid adduct formation in cells
To follow the fate of 15d-PGJ 2 , BT-15d-PGJ 2 was prepared as described previously [8] . For the detection of protein adducts, BAECs were grown in 0.5 % FBS for 24 h and then treated with either 10 μM BT-15d-PGJ 2 (30 min-16 h) or increasing concentrations of BT-15d-PGJ 2 for 4 h. Cells were washed with PBS and harvested in 10 mM Tris/HCl and 1 % (v/v) Triton X-100 (pH 7.4) containing Mini-Complete TM PIC (protease inhibitor cocktail) (Roche). Cell lysate proteins were separated by SDS/PAGE (10 % gels) and transferred on to a nitrocellulose membrane at 100 V for 2 h. After blocking with 5 % (w/v) nonfat dried skimmed milk powder in TBS-T (Tris-buffered saline with 0.05 % Tween 20) for 1 h, the membranes were probed with HRP (horseradish peroxidase)-conjugated streptavidin (GE Healthcare) in TBS-T and developed using a chemiluminescence imager (Alpha Innotech). In addition, 10 ng and 20 ng of BTcyt c (biotinylated cytochrome c) (biotin levels are 2.41 pmol and 4.82 pmol respectively) were used as internal standards to calibrate the adduct formation in cell lysates [35] .
Determination of lipid adduct distribution between cellular and media proteins
To determine the distribution of protein adducts by BT-15d-PGJ 2 between cells and media, BT-15d-PGJ 2 (7.5 μM) was added to medium containing 0 % or 0.5 % FBS for 4 h. The total amount of lipid added to the medium in these experiments was verified spectrophotometrically by using the characteristic absorbance of BT-15d-PGJ 2 at 306 or 315 nm and corrected for any background absorbance of the medium as described above. Media were then collected and cells were lysed in 10 mM Tris/HCl and 1 % (v/v) Triton X-100 buffer (pH 7.4) with PIC, and the pellets were washed with PBS. After centrifugation at 2800 g for 10 min, the cell pellets were sonicated in 10 mM Tris/HCl and 2 % (w/v) SDS (pH 6.8) with PIC for 20 min. Protein content was determined by Lowry assay, and BT-15d-PGJ 2 adduct on proteins was measured as described previously [35] . Proteins were visualized using Sypro Ruby stain (Molecular Probes) with a CCD (charge-coupled device) camera imager equipped with a SYPRO-500 filter (Alpha Innotech).
To determine the extent of modification of Keap1 by 15d-PGJ 2 , confluent cells were treated with BT-15d-PGJ 2 at a range of concentrations and for various periods of time. After the treatment, cell lysates were prepared as described above. Biotinylated proteins were affinity-precipitated using 100 μl of a 50 % slurry of NeutrAvidin beads (Pierce) washed six times with 20 mM Tris/HCl (pH 7.4). Cell lysates (500-800 μg of protein) were added to the beads containing PIC and incubated overnight at 4
• C with rotation. Beads were then washed six times with 500 μl of 0.1 M glycine (pH 2.8), followed by washing with 1 ml of 20 mM Tris/HCl (pH 7.4). Samples were then prepared for analysis by heating the beads to 80
• C for 10 min in 80 μl of 2× sample buffer (0.1 M Tris/HCl, 4 % SDS, 10 % glycerol and 0.2 % Bromophenol Blue, pH 6.8) containing 2-mercaptoethanol to release the biotin-labelled proteins. Samples were then centrifuged at 17 500 g for 10 min at 4
• C, and supernatants were used for analysis. Proteins were separated by SDS/PAGE (10 % gels), and transferred on to a nitrocellulose membrane at 100 V for 2 h and membranes blocked with 5 % (w/v) non-fat dried skimmed milk powder in TBS-T. Membranes were incubated with polyclonal primary antibody against Keap1 (E-20; Santa Cruz Biotechnology), diluted 1:1000 in 5 % (w/v) non-fat dried skimmed milk powder in TBS-T, followed by a HRP-conjugated donkey anti-goat secondary antibody (Santa Cruz Biotechnology), diluted 1:1000 in 5 % (w/v) non-fat dried skimmed milk powder in TBS-T. Membranes were developed by chemiluminescence using SuperSignal West Dura substrate (Pierce), and sequential images were taken with quantification only performed on bands which had not reached saturation, as described in [36] .
Determination of GSH and HO-1 levels
After incubation with 15d-PGJ 2 or BT-15d-PGJ 2 , cells in each well were washed twice with 2 ml of 10 μM DTPA (diethylenetriaminepenta-acetic acid) in PBS and lysed in the presence of lysis buffer (10 μM DTPA and 0.1 % Triton X-100 in PBS, pH 7.4) containing PIC. Protein content was assayed using the Bradford method (Bio-Rad Laboratories). Total glutathione (GSH+GSSG) levels were determined as described previously and are expressed relative to cell lysate protein [12] . To determine HO-1 protein expression, cell lysate proteins were separated by SDS/PAGE (10 % gels) and transferred on to nitrocellulose at 100 V for 2 h before membranes were blocked with 5 % (w/v) non-fat dried skimmed milk powder and 1 % BSA in TBS-T. Membranes were incubated with polyclonal primary antibody against HO-1 (SPA-896; Stressgen), diluted 1:3000 in 5 % (w/v) non-fat dried skimmed milk powder and 1 % BSA in TBS-T, followed by a HRP-conjugated donkey anti-(rabbit IgG) secondary antibody (NA934V; GE Healthcare Amersham), diluted 1:5000 in 5 % non-fat dried skimmed milk powder in TBS-T. Membranes were developed by chemiluminescence using SuperSignal West Dura substrate, and sequential images were taken with quantification only performed on bands which had not reached saturation.
Statistical analysis
Data are reported as means + − S.E.M. for n = 3-9, as indicated in the legends. Statistical significance was evaluated by oneway or two-way ANOVA among the groups using SPSS window (version 8.0). The minimum level of significance was set at P < 0.05. The LSD (least significant difference) test was used as a post-hoc test for the significant difference between groups.
RESULTS

Quantification of protein adducts upon addition of BT-15d-PGJ 2 to endothelial cells in culture
To establish the time course and concentration-dependence for protein adduct formation mediated by 15d-PGJ 2 , BAECs were treated for the times shown with BT-15d-PGJ 2 (10 μM) or a range of concentrations for 4 h (Figure 1 ), and the amount of protein adducts was quantified using a biotinylated internal standard protein [35] . Two bands were detected in either the untreated cells (result not shown) or at the zero time point which are due to the endogenous biotin-containing carboxylases. Protein adducts in the samples containing 10 μM BT-15d-PGJ 2 increased over time, reaching a maximum of approx. 1 nmol/mg of protein at 4-5 h ( Figure 1A ). The formation of protein adducts was also dependent on the concentration of BT-15d-PGJ 2 ( Figure 1B) . No toxicity was detected in the presence of BT-15d-PGJ 2 after 4 h, but cell death occurred in the presence of 20 μM BT-15d-PGJ 2 at 16 h (results not shown) as reported previously [12] . 
Effect of serum on the distribution of protein adduct formation by BT-15d-PGJ 2 and induction of HO-1 synthesis
It has been shown previously that the presence of serum in the medium can decrease the signalling in epithelial cells through a competing reaction with BSA which appears to prevent access to the cells [37] . We confirmed this result by adding 15d-PGJ 2 (0-1 μM) to the cells either directly or after pre-incubation for 5 min in medium containing 0.5 % FBS followed by incubation for 16 h and measurement of HO-1 levels ( Figure 2A) . As a further test of the inhibitory effect of serum, 15d-PGJ 2 (5 μM) was added directly to BAECs with and without 0.5 % FBS, and HO-1 levels were measured after 16 h. As shown in Figure 2 (B), the presence of FBS decreased HO-1 induction by approx. 90 %.
Using the conditions defined in Figure 2 (B), adduct formation was determined in the medium, cell lysate and SDS-solubilized cell pellet. In this experiment, the amount of lipid added to the cells was 7.5 μM (15 nmol total), and the distribution of BT-lipid (biotinylated lipid) in the different fractions is shown in Figure 3 and Table 1 . The levels of protein adduct formation on a number of the protein bands (indicated with arrows, Figure 3A) were decreased by the presence of FBS. Quantification of these experiments indicated that 2.8 % of the total BT-lipid added in the absence of FBS formed protein adducts compared with 0.35 % in its presence (Table 1) . Protein adduct formation was detected in the medium on BSA (Figure 3B ), which accounted for another 0.2 % of adducts in the presence of FBS. Taken together, these data demonstrate that the pool of 15d-PGJ 2 capable of forming covalent adducts in the cell decreased over a short time period by interaction with serum.
Determining the concentration of 15d-PGJ 2 required to induce GSH and HO-1 in BAECs
In the next series of experiments, we assessed cell signalling induced by 15d-PGJ 2 using both GSH and HO-1 protein levels, which are sensitive indicators of the covalent modification of Keap1 and subsequent activation of the EpRE. To establish a concentration-dependence for 15d-PGJ 2 in regulating these antioxidants, BAECs were exposed to increasing concentrations of 15d-PGJ 2 in serum-free medium. After 4 h of incubation, the lipid-containing medium was removed and replaced with fresh medium containing 0.5 % FBS, and the cells were incubated for a further 12 h before lysis and measurement of total GSH or HO-1 protein. Figure 4 shows the data for both GSH induction ( Figure 4A ) and HO-1 ( Figure 4B ) as a function of both the nominal concentration of 15d-PGJ 2 added to the medium and also adjusted for the loss to the cell culture medium (97 %; Table 1 ). As has been reported previously, we found that the levels of GSH increase at least 4-fold on exposure to 15d-PGJ 2 ( Figure 4A ). In the case of HO-1, a significant increase was only detected at nominal concentrations of 1 μM 15d-PGJ 2 or above ( Figure 4B ). Table 1 . Values are means + − S.E.M. (n = 3). The BT-15d-PGJ 2 protein adduct formation was determined in the medium, cell lysate and SDS-solubilized cell pellet according to the internal standard (BT-cyt c) from a Western blot using HRP-conjugated streptavidin (for cell lysate and pellets) or spectrophotometric analysis (for medium). N.D., not detected. 
Effect of time on the induction of GSH and HO-1 by 15d-PGJ 2 in BAECs
The data in Figure 1 suggest that increasing the time of exposure of 15d-PGJ 2 to the cells should increase the final level of GSH or HO-1. To test this, cells were incubated with 2 μM 15d-PGJ 2 , and statistical significance was evaluated by one-way ANOVA, followed by the LSD as a post-hoc test.
* P < 0.05; * * P < 0.01; * * * P < 0.001; * * * * P < 0.0001 compared with control (0 μM 15d-PGJ 2 ). A.U., absorbance units.
in the absence of FBS for 2, 4 or 8 h after which the lipid was removed by changing the medium, and cells were incubated for a further 16 h. In these experiments, the lower-molecular-mass band detected in the HO-1 Western blot represents a recently described processed form of the enzyme and was included in the quantification of the protein [38] . Measurement of GSH or HO-1 in these cells revealed that a longer exposure to 15d-PGJ 2 resulted in a higher level of GSH or HO-1 ( Figures 4C and 4D ). This response was not linear, however, since the cells with shorter exposures showed disproportionately lower levels of both GSH and HO-1. This threshold effect was not due to saturation of the signal for either HO-1 or GSH in cells with longer exposures, since preliminary experiments indicated that these levels for both antioxidants were approx. 50-70 % of the maximum levels that can be achieved (results not shown). Control experiments in which the vehicle was added under similar conditions indicated that the time of incubation under serum-free conditions had no impact on the basal GSH or HO-1 levels (results not shown).
Effect of medium volume on the induction of GSH and HO-1 by 15d-PGJ 2
In the vasculature, endothelial cells are exposed to blood containing electrophiles at low concentrations. To model this effect, we varied both the volume of medium (1-4 ml) and concentration of 15d-PGJ 2 to which cells were exposed and determined the resulting levels of GSH and HO-1. The concentration-dependence for the induction of GSH for two volumes (1 and 4 ml) are shown in Figure 5(A) . The inset (n = 3) and statistical significance among the groups was evaluated as described in Figure 6 . * P < 0.01; * * P < 0.001 between groups. A.U., absorbance units.
shows the lower part of the dose-response curves for GSH and demonstrates that, even at very low concentrations of the electrophile, exposure of the cells to the same concentration at a higher volume results in a greater induction of antioxidant. When the same samples were also analysed for HO-1 induction, a similar pattern was observed. A potentiation of the effects of 2 μM 15d-PGJ 2 occurs in larger volumes of medium, which corresponds to increasing amounts (2, 4 and 8 nmol) of the lipid ( Figure 5B ). These data are consistent with a response to 15d-PGJ 2 that is sensitive to both the concentration and absolute amount of lipid to which the cells are exposed. Thus GSH and HO-1 levels increase as the volume of a fixed concentration of 15d-PGJ 2 is increased.
Importance of length of exposure and amount of electrophile in determining induction of HO-1 and GSH through covalent adduct formation with Keap1
On the basis of the previous experiments, we predicted that lower concentrations of lipid will accumulate adducts with signalling proteins more slowly, thus requiring more time to obtain the same biological response. In other words, if the amount of the electrophile is kept constant and the volume of the media doubled (i.e. the lipid concentration is decreased by half), the time taken to achieve the same biological response will also double. This experiment was performed as described in the scheme shown in Figure 6 (A), where cells were exposed to a constant amount (4 nmol) of 15d-PGJ 2 in different volumes (shown in parentheses) for the times shown. As before, both GSH and HO-1 were measured and are reported as a function of 15d-PGJ 2 concentration. It is evident from these data that increased time of the cells' exposure to lipid leads to increased GSH levels at all concentrations tested. From Figure 6 (A), it is also clear that the time taken to reach a fixed level of cellular GSH (e.g. 150 nmol, broken line) increases as the concentration of 15d-PGJ 2 to which the cells are exposed decreases. These samples were also assessed for changes in HO-1 levels in the cell ( Figure 6B ). Although there was little or no response after only 2 h, cells exposed to 2 μM 15d-PGJ 2 for 4 h resulted in similar levels of HO-1 to those in cells exposed to 1 μM 15d-PGJ 2 for 8 h. These data predict that similar responses in the formation of covalent protein adduct formation with Keap1 will also occur. To test this, cells were prepared as described in Figure 6 (A). Levels of Keap1 ( Figure 7A , top panels) and actin (results not shown) were determined by Western blot analysis and did not change in response to BT-15d-PGJ 2 . Samples were then subjected to affinity-purification of biotinylated proteins. We found that a small amount of contaminating Keap1 was pulled down in the control samples, together with actin and other cytoskeletal proteins. This is most likely to be due to the non-specific association of actin with the NeutrAvidin resin used for the affinity-purification. As can be seen in Figures 7(A) and 7(B) , on exposure to BT-15d-PGJ 2 the amount of Keap1 retained on the NeutrAvidin resin increased over time, a result consistent with increased lipid adduct formation with Keap1. In contrast, the amount of actin retained on the resin remained relatively constant and was used as a normalizing control. These data strongly indicate for the first time that adduct formation with endogenous Keap1 is formed with low levels of lipid electrophiles and accumulate over time. Next, we used the same experimental design to determine the effect of time of lipid exposure and concentration on Keap1 adduct formation. We found that lipid adduct formation with Keap1 was the same at different concentrations (but the same amount) of 15d-PGJ 2 ( Figure 7C ). Taken together, these data show that, if sufficient time is allowed for covalent adducts to accumulate, the amount of Keap1 associated with the NeutrAvidin resin is essentially the same (horizontal broken line in Figure 7D ).
Comparison of the effects of bolus or sequential additions of low concentrations of 15d-PGJ 2 on the induction of GSH and HO-1 in BAECs
As a further test of whether the signal for induction of GSH or HO-1 can accumulate over time, we selected one of the lowest amounts of 15d-PGJ 2 which could result in detectable levels of GSH or HO-1 (2 nmol) and added to BAECs as either one bolus addition or 20 sequential additions of 100 pmol each per day for 1-3 days. This is equivalent to a concentration of 25 nM for each addition which is within the range of 15d-PGJ 2 levels that could be produced in cell culture by COX-2 [11] . The time between each addition was selected as 20 min on the basis of the data shown in Figure 2 which shows rapid inactivation of 15d-PGJ 2 5 min after addition to the medium. The basal levels of both GSH and HO-1 increase with lower cell density, and, for this reason, the responses are expressed as fold changes relative to a control cultured under similar conditions. As shown in Figure 8 , the levels of GSH were induced approx. 2-fold by the bolus addition of 15d-PGJ 2 and a slightly lesser amount (approx. 1.7-fold) after addition of the same amount of the lipid in 100 pmol aliquots. Importantly, this response to 15d-PGJ 2 was sustained over 3 days. In the case of HO-1, the bolus addition of 15d-PGJ 2 resulted in an approx. 2-fold increase in the levels of HO-1 and this was increased with sequential additions of 100 pmol to approx. 2.7-fold and was again responsive over the 3 days of the experiment.
DISCUSSION
A number of lines of evidence support the concept that endogenous formation of COX-derived electrophilic lipid oxidation products may play an anti-inflammatory role [3, 6, 9, 24, [39] [40] [41] [42] [43] . These findings have also led to the suggestion that exogenous administration of these lipids has potential anti-inflammatory properties. It is thus important to understand their biochemical properties and mechanisms of action [24, [44] [45] [46] [47] . Several studies have defined potential mechanisms through which the antiinflammatory effects may be elicited by 15d-PGJ 2 , and these include inhibition of the NF-κB signalling pathway, induction of antioxidant defences, and potentiation of apoptosis in macrophages [8, 10, 39, [48] [49] [50] . These findings have generated considerable interest since they explain how COX-2 activity may contribute to the resolution of inflammation [10] . In endothelial cells, one mechanism leading to induction of COX-2 and other cytoprotective proteins is the shear stress caused by laminar blood flow [51, 52] . Recently, it has been shown that laminar, but not turbulent, flow stimulates the activation of the Nrf-2-Keap1 pathway through a COX-2-dependent mechanism [27] . Laminar flow has also been shown to increase both GSH and HO-1 [27, 51, 53] . Importantly, the Nrf-2-Keap1 pathway is also activated by the addition of exogenous electrophilic cyclopentenones such as 15d-PGJ 2 [8, 12, 13, 23, 54] . Interestingly, the free concentrations of both 15d-PGJ 2 and its precursor PGD 2 . Statistical significance among the groups was evaluated by one-way ANOVA, followed by the LSD as a post-hoc test.
* P < 0.0001 compared with control within the groups (bolus or Day 1-3 group); #P < 0.0001 between lipid-treated groups or bolus to sequential treatment (Day 1-3) . A.U., absorbance units; Cnt, control.
were determined in the medium after flow and found to be approx. 0.5-1 nM [27] . A number of studies have reported similar concentrations of free 15d-PGJ 2 in a wide range of tissue and cell culture conditions, as well as plasma levels in human patients [11, 40, 42, 43, 55, 56] . However, the levels of free 15d-PGJ 2 that can be measured in vivo are far lower than those required in vitro to modulate the same signalling pathways, and this point has led to some controversy over the biological relevance of this lipid [27, 28, 56] . For example, it has been shown that the concentrations of 15d-PGJ 2 found in adipocytes are lower than those predicted for the activation of PPARγ [28] . This is also the case for the activation of the Nrf-2-Keap1 pathway, which leads to the synthesis of antioxidants such as GSH or HO-1 [27] . We hypothesized that cell culture conditions used to recapitulate 15d-PGJ 2 exposure in vivo result in a substantial loss of the electrophile, thereby preventing the covalent protein adduct formation required for Nrf-2-Keap1 activation. We also reasoned that the formation of covalent protein adducts in the cell is a more accurate reflection of the amount of 15d-PGJ 2 available to initiate cell signalling in cell culture experiments.
In the present study, we have tested this hypothesis using a number of approaches. First, we used BT-15d-PGJ 2 in combination with a biotinylated protein standard to determine the absolute amount of lipid-protein adducts formed in endothelial cells [35] . We have demonstrated previously that this tagged analogue of 15d-PGJ 2 forms a covalent adduct with Keap1 and this is responsible for the induction of GSH synthesis in endothelial cells [8] . Others have demonstrated induction of HO-1 by electrophiles through the EpRE, and we and others have demonstrated induction of HO-1 by 15d-PGJ 2 [51, 57, 58] . Earlier studies with radiolabelled electrophilic cyclopentenones demonstrated that the lipids were irreversibly associated with cellular proteins and the label accumulated over time consistent with covalent protein adduct formation [59] . In the present study, we have shown that covalent protein adduct formation in general, and with Keap1 specifically, is dependent on both the concentration of 15d-PGJ 2 and the time of exposure (Figures 1  and 7) . We also found that, although micromolar concentrations (0-40 nmol) of 15d-PGJ 2 were added to the cells, only picomolar amounts of adduct were detected on cellular proteins (Figures 1  and 3 , and Table 1 ). Inactivation occurred upon addition to the cell culture medium and was enhanced by the presence of FBS. In addition, inactivation of 15d-PGJ 2 does not require cells, indicating that the failure of the 15d-PGJ 2 to react with cellular proteins and up-regulate HO-1 and GSH is not due to cellular metabolism of the lipid. These results are consistent with other reports using radioactively labelled 15d-PGJ 2 which show that a small proportion (less than 5 %) of the lipid is associated with cell proteins when added to fibroblasts in culture [28] . Previous studies have also suggested that BSA can interact with 15d-PGJ 2 [37] , and, in the present study, we have demonstrated that 15d-PGJ 2 does in fact covalently modify BSA.
Importantly, the inactivation of 15d-PGJ 2 decreased the amount of electrophile available for the induction of HO-1 ( Figure 3 and Table 1 ). For the first time, the extent of this decrease has been quantified and is substantial, with approx. 97-99 % of the amount of 15d-PGJ 2 unavailable to either form protein adducts or initiate cell signalling. This result may explain the enormous variability in literature reports in the concentrations of 15d-PGJ 2 required to elicit cell signalling [8, [28] [29] [30] . In addition, these data now allow us to reassess the amount of 15d-PGJ 2 that is available to initiate the induction of GSH and HO-1 on addition of the pure lipid to cell culture medium (Figure 4 ). For example, we can calculate that the addition of 1 nmol of BT-15d-PGJ 2 , which is sufficient to induce both GSH and HO-1 synthesis, results in only 30 pmol adducted to cellular protein. In the case of the human subjects, this would be the amount present in approx. 100 ml of plasma containing 0.33 nM 15d-PGJ 2 [55] .
In assessing the formation of protein adducts by BT-15d-PGJ 2 we found that these adducts increase progressively with time up to a period of approx. 4 h. We also found that the induction of both GSH and HO-1 also increased over a similar timespan and this was associated with increasing modification of Keap1 by the electrophile (Figures 4 and 7) . This is important, since lower concentrations of electrophilic lipid will form covalent adducts with proteins more slowly and explains why more time is required at lower concentrations of 15d-PGJ 2 to activate the signalling pathways leading to HO-1 or GSH induction ( Figure 6 ). Taken together, our experiments revealed that three key factors, which have not been considered previously, make a major contribution to the magnitude of the cell signalling in response to 15d-PGJ 2 and the consequent synthesis of GSH or HO-1. These are as follows.
(i) The importance of considering the total amount (i.e. number of molecules) of 15d-PGJ 2 to which the cells are exposed in contributing to the final response of cells to electrophilic lipids.
(ii) Concentration also plays a role in determining the time of exposure to 15d-PGJ 2 needed to result in increased levels of GSH or HO-1. Higher concentrations of 15d-PGJ 2 resulted in more rapid responses, whereas low concentrations in higher volumes have the potential to achieve similar biological responses given sufficient time (Figures 6-8) .
(iii) An equivalent biological response can be achieved by sequential additions of low concentrations of 15d-PGJ 2 over time as a bolus addition of a single higher concentration of the same absolute amount of lipid (Figure 8 ).
In summary, we have demonstrated that the minimum concentrations of 15d-PGJ 2 required to activate signalling pathways in cells are approx. 1-2 orders of magnitude lower than that assumed from the amounts added to the medium. In addition, the formation of covalent adducts is a key element of the cell signalling pathway that enhances the sensitivity of these pathways to low concentrations of electrophiles over time. Although this was not addressed in the present study, the data also suggest that metabolism by GSH-dependent mechanisms, including the glutathione transferases, will decrease substantially under conditions below the K m for these enzymes where low levels of electrophile-protein adducts accumulate over time. These data also have important implications, not only for the cell signalling mediated by electrophilic lipids, but also for other mechanisms of redox cell signalling which involve the post-translational and stable modification of cell signalling proteins. The accumulation of protein adducts over time allows the cell to sense the 'redox tone' of the cellular milieu [5, 6] . In complex biological processes such as inflammation, this provides a mechanism through which cellular responses can be modulated over the hours or days over which these biological processes evolve. 
